Generic Medicine Info
Indications and Dosage
Short-term management of anxiety
Adult: As short-term treatment: 10-30 mg daily in divided doses. Severe conditions: Up 60 mg daily.
Elderly: and debilitated patients: Dose reductions required.
Special Precautions
Severe hepatic impairment. Elderly or debilitated patients; muscle weakness or myasthenia gravis; impaired liver or kidney function; predisposition to seizures; depression; severe respiratory dysfunction; sleep apnoea; movement disorders; drowsiness may affect skilled tasks; history of alcohol or drug addiction. Treatment withdrawal should be gradual. Avoid long-term use. Pregnancy and lactation.
Adverse Reactions
Fatigue, drowsiness, dizziness, prolonged reaction time, headache, coordination disorders (ataxia), confusion, anterograde amnesia. Rarely, GI symptoms, laryngeal spasm, chest pain, hypotension, bradycardia, depression, decreased libido, increased appetite, dry mouth, muscle weakness, respiratory failure.
Drug Interactions
Additive CNS depression or sedative effects with drugs that have CNS depressant properties e.g. alcohol, antidepressants, sedating antihistamines, antipsychotics, general anaesthetics, other hypnotics or sedatives, opioid analgesics, cisapride.
Potentially Fatal: Increased risk of toxicity with hepatic microsomal enzyme inhibitors.
Mechanism of Action: Medazepam is a long-acting benzodiazepine used for the short-term treatment of anxiety disorders.
Absorption: Absorbed rapidly from the GI tract (oral); peak plasma concentrations after 1-2 hr.
Metabolism: Hepatic; metabolised to diazepam and desmethyldiazepam.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Medazepam from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in